IMPORTANCE Alterations in ocular blood flow play an important role in the pathogenesis and progression of diabetic retinopathy (DR). However, the measurement of retinal blood flow in clinical studies has been challenging. En face Doppler optical coherence tomography (OCT) provides an effective method for measuring total retinal blood flow (TRBF) in the clinic.
D iabetic retinopathy (DR) is the leading cause of legal blindness among working-age adults in developed countries. [1] [2] [3] Because of their important role in the development of DR, alterations of the retinal microvasculature in eyes with DR have been extensively studied in vivo using fluorescein angiography and indocyanine green angiography techniques and, more recently, optical coherence tomography (OCT) angiography. These investigations have detailed a variety of microvascular alterations, including microaneurysms, capillary dropout, and remodeling; interestingly, recent studies have also found these alterations to be present in some diabetic eyes without clinically apparent retinopathy. [4] [5] [6] Despite the successes of fluorescein angiography/indocyanine green angiography and OCT angiography studies in identifying important diagnostic markers for DR, the underlying mechanisms of the pathogenesis and progression of DR are still incompletely understood. The importance of retinal blood flow (RBF) in DR has also motivated investigations of total RBF (TRBF) in diabetic eyes. Researchers have used a variety of techniques to measure RBF changes in DR, including video fluorescein angiography, 7,8 laser Doppler velocimetry, 9-14 and color Doppler ultrasound imaging. 15 Results from these studies provided a mixed picture of RBF in diabetic patients. In particular, while a majority of the studies noted increased flow in nonproliferative DR (NPDR), [7] [8] [9] [10] [11] [12] a few noted decreased flow. 13, 14, 16 Results from studies in eyes with proliferative DR (PDR) were similarly mixed. measures blood flow in the plane perpendicular to the OCT beam ( Figure 1 ). In particular, by scanning a small volume at the optic disc, one can compute the TRBF by integrating the axial blood flow velocity in the central retinal artery. [24] [25] [26] With high-speed imaging sufficient to acquire the entire volumes, en face Doppler OCT enables a fully automatic measurement of TRBF, which is important for performing studies on larger cohorts. In a small study of 10 healthy participants, the en face Doppler demonstrated good repeatability, with a 6.1% median coefficient of variation.
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Methods
The study was a comparative analysis of TRBF in eyes from diabetic patients and age-matched healthy controls. 
Study Population
In this study, diabetic patients with or without DR and healthy controls were seen at the retina service of the New England Eye Center between May 23, 2014, and January 11, 2016, and were prospectively recruited to be imaged with the OCT prototype system. Blood pressure was measured during the OCT imaging session; intraocular pressure and axial eye length were recorded at the same visit. Ocular perfusion pressure was calculated as the difference between the mean blood pressure and intraocular pressure. The inclusion criteria for the DR group were diabetic patients presenting vascular changes consistent with DR, with or without diabetic macular edema (DME), as diagnosed by a retina specialist based on a complete clinical examination, including 
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mild but less than severe NPDR); (3) severe NPDR (>20 intraretinal hemorrhages in each of the 4 quadrants, venous beading in at least 2 quadrants, and intraretinal microvascular abnormalities in at least 1 quadrant in the absence of PDR); and (4) PDR (optic disc or retinal neovascularization). 29 Exclusion criteria for the DR group were the presence of any concurrent ocular or systemic disease that would act as a confounding factor (age-related macular degeneration, hypertensive retinopathy, glaucoma, retinal vein or artery occlusion, a refractive error of >6 diopters, or uveitis) and media opacity. Healthy controls were excluded if any ocular or systemic disease that potentially affects the vasculature was present.
The eyes of diabetic patients were classified as either with DR or without DR. The eyes with DR were stratified into 2 groups according to the presence or absence of DME. Each of these 2 groups was then further stratified into 3 groups according to disease severity: mild NPDR, moderate NPDR, and severe NPDR/PDR ( Table 1) .
High-Speed Swept-Source OCT Instrumentation
En face Doppler OCT was performed using a high-speed, sweptsource/Fourier-domain OCT prototype system, which has been described previously. 30, 31 The system used a 1050-nm vertical cavity surface-emitting laser with a tunable light source enabling 400 000 A-scans per second. When compared with the 840-nm systems used in commercial spectral/Fourier-domain OCT, the high-speed, 1050-nm wavelength, swept-source OCT system used in this study has 2 advantages. First, attenuation from light scattering is lower at longer wavelengths, improving the signal penetration into the large retinal vessels located at relatively deep depths into the optic nerve. Second, the longer wavelength, in conjunction with the higher imaging speed, reduces the amount of Doppler phase wrapping in the fast-flowing vessels, thereby simplifying measurement of axial flow velocity. En face Doppler OCT was performed by repeatedly acquiring 600 × 80 A-scan volumes, each covering a 1.5 × 2-mm 2 area
at the optic disc. The B-scans were laterally oversampled to maintain a high correlation between the neighboring A-scans to ensure the quality of Doppler images. For each TRBF measurement, 24 volumes were acquired at a rate of 7.1 volumes per second, requiring a total acquisition time of 3.4 seconds. The image acquisition sequence was repeated 4 times to assess the repeatability of the TRBF measurement, although 1 measurement was randomly chosen for data analysis because some of the repeated measurements were invalid owing to low signal or excessive eye motion in some participants.
The OCT data processing proceeded in 2 independent phases. First, the raw data were converted into intensity and Doppler B-scans. Then, the volumetric blocks of intensity and Doppler images were loaded, and the TRBF in each en face plane was calculated in a continuous range of depths. A combination of image filters, histogram analyses, and morphologic operations were optimized for segmentation of the central retinal arterial area. To improve segmentation accuracy at diastoles when flow velocity is low, hysteresis thresholding was applied inside the segmented vessel area at the most recent systole. For this purpose, translational motion was corrected by registering each volume to the volume acquired at the most recent systole. After the TRBF measurements in all 24 volumes were computed, the mean TRBF was calculated as the average of the TRBF over an integer number of cardiac cycles.
Statistical Analysis
A linear mixed-effects model was used to test the significance of TRBF difference between 2 groups, in order to separately consider the variation among different participants and the variation between 2 eyes of the same participant. For comparison of other measurements such as blood pressure, intraocular pressure, and ocular perfusion pressure between 2 groups, the Mann-Whitney U test was used for simplicity. A 2-tailed P ≤ .05 was considered to be statistically significant. years; 8 were female participants) were included in the analysis. The treatment history for the 17 eyes having DME and moderate or severe NDPR is given in Table 2 .
Results
Forty
There was no significant difference in mean blood pressure or mean ocular perfusion pressure between control and DR groups. As a group, diabetic patients without DR exhibited a significantly higher mean blood pressure (P ≤ .05) and a higher mean ocular perfusion pressure (P ≤ .05) than the healthy participants. The mean (SD) TRBF was 44.4 (8.3) μL/min in the healthy eyes, 40.1 (7.7) μL/min in the eyes of diabetic patients without DR, 48.8 (13.4) μL/min in the eyes with DR but without DME, and 28.0 (8.5) μL/min in the eyes with DR and DME. As shown in Figure 2A , TRBF was significantly decreased in the eyes with DR and DME compared with the healthy eyes (P ≤ .001, determined by use of the linear mixed-effects model) and the eyes with DR but without DME (P ≤ .001, determined by use of the linear mixed-effects model). Note that the eyes with mild NPDR were excluded for this comparison to prevent disease severity from being a confounding factor. Comparison of TRBF between the treatment-naive (28.7 [7.6] μL/min) and treated (27.0 [9.8] μL/min) DME groups showed no significant separation between the 2 groups (P > .50). For this series of statistical tests, the eyes with mild NPDR were excluded in order to match retinopathy severity between the eyes with DR but without DME and the eyes with DR and DME. Figure 2B illustrates that the eyes with DME had a significantly lower TRBF than did the healthy eyes, regardless of retinopathy severity. TRBF with respect to DR severity and presence or absence of DME
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The horizontal line in the middle of each box indicates the median, while the top and bottom borders of the box mark the 75th and 25th percentiles, respectively. The whiskers above and below the box mark the minimum and maximum. DM indicates diabetes mellitus; DME, diabetic macular edema; DR, diabetic retinopathy; NPDR, nonproliferative DR; PDR, proliferative DR.
Among eyes with DME, the mean (SD) TRBF was 30.7 (10.2) μL/min (P ≤ .002) for the mild/moderate NPDR group and 22.8 (5.6) μL/min (P ≤ .002) for the severe NPDR/PDR group, both being significantly lower than in healthy controls. In contrast, TRBF in eyes without DME was not lower compared with the healthy controls. The eyes with mild NPDR but without DME had a mean (SD) TRBF of 45.4 (9.2) μL/min, which was similar to the TRBF in the healthy eyes. In the eyes with severe NPDR or PDR, but without DME, the mean (SD) TRBF was 52.2 (12.2) μL/min, which is higher than the TRBF in the healthy eyes, but the difference was not statistically significant (P > .05). Finally, in eyes with moderate NPDR but without DME, the mean (SD) TRBF was 49.5 (19.1) μL/min, covering a wide range from 31.1 to 75.0 μL/min.
Discussion
Perhaps the most noteworthy finding of this study is that the eyes with DME exhibit markedly reduced TRBF irrespective of treatment history or DR severity. A study by Guan et al 32 investigated RBF in the superior temporal arterioles of eyes with DR using the Canon Laser Blood Flowmeter. The ratio between the maximum and minimum flow velocities, often referred to as vascular resistivity, was suggested to be a risk factor for DME. However, significant differences were not detected in the vessel diameters, the flow velocity, or the TRBF. 32 Our results showing reduced TRBF in DME are not in agreement with these findings. However, it is important to note that the repeatability of the single-vessel blood flow measurement using the Canon Laser Blood Flowmeter is relatively poor-the coefficient of variation in healthy participants was reported to range from 4.8% to 39.7%, and the median was 19.9%. 33 In contrast, in a study of healthy eyes, the en face Doppler OCT method was reported to have a coefficient of variation ranging from 0.8% to 10.9%, with a median of 6.1%. 27 In the present study, the coefficient of variation in the 23 eyes with DR with more than 3 valid TRBF measurements fell in between 1.8% and 11.0%, and its median was 7.0%. With regard to a potential causal relationship between reduced TRBF and DME, some groups have commented that the increased tissue hydrostatic pressure associated with DME may cause displacement and disruption of the smaller capillaries and may result in reduced TRBF. Conversely, recent studies have suggested that leukostasis, the accumulation of leukocytes on the luminal surface of the retinal capillaries, could be a major contributor to the dysfunction of the blood-retinal barrier and the development of capillary nonperfusion in diabetic patients.
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Histopathologic studies have shown that microaneurysms in DR may be engorged with leukocytes, red blood cell breakdown products, and eventually fibers, impeding flow in the retinal microvasculature. 35 It may be that ischemia, as measured by reduced TRBF, creates an environment rich in vascular endothelial growth factor (VEGF) that precipitates DME. 36 There is now evidence in the OCT angiography literature demonstrating that loss of capillary perfusion is correlated with DR severity [37] [38] [39] and that DME is accompanied by loss of perfusion in the retinal capillaries, especially in the deep capillary plexus, and that these changes may precede the development of edema. [40] [41] [42] Interestingly, in the eyes with moderate NPDR but without DME, a strongly skewed distribution covering a wide range of TRBF measurements was observed ( Figure 3 ). This distribution suggests that there may be 2 clusters within the group: the subgroup with a higher TRBF could exhibit a similar TRBF as in the DME-absent severe NPDR/PDR group, and the subgroup with a lower TRBF could have TRBF values close to those in the groups with DME. However, the present study is very preliminary, and it is beyond the scope of this study to draw any definitive conclusions on how DME and reduced TRBF are related. According to the prevailing theory in the laser Doppler velocimetry literature, the TRBF in eyes with NPDR is expected to be higher than normal and increasing with increasing disease severity.
7-12,43,44 Our measurements in the DME-absent eyes with severe NPDR or PDR suggest that there could be a slight increase in TRBF in these groups, although statistical significance was not demonstrated, perhaps owing to the small group sizes. Investigators have postulated that an increased glucose level in a patient with diabetes may be responsible for increased TRBF. Laser Doppler velocimetry studies on type 1 diabetes 45 and type 2 diabetes 46 without clinically pronounced retinopathy showed that a decrease in insulininduced blood glucose level caused a transient decrease in RBF. Meanwhile, one of these studies also showed that the diabetic patients without retinopathy presented with a lower temporal RBF than was found in healthy controls. These results must be interpreted with caution because insulin reduces hyperglycemia and dilates the blood vessels at the same time. It is difficult to speculate on any pathophysiological causes considering the small size of this study. It is worth noting the possible influence of anti-VEGF treatment on TRBF in the eyes with DME because anti-VEGF agents have been linked to transient reductions in RBF. [47] [48] [49] [50] [51] For the 6 eyes that received anti-VEGF treatment, the injections were given based on a treat-and-extend protocol. Therefore, the timing of the injections was different for all 6 eyes. Three eyes were treated with anti-VEGF no more than 60 days prior to the en face Doppler imaging, and their mean (SD) TRBF was 25.3 (9.2) μL/min. The other 3 eyes had not received any anti-VEGF treatment within 120 days before the en face Doppler measurement, and their mean (SD) TRBF was 29.4 (5.2) μL/min. The similarity of the TRBF measurements in the 2 groups is consistent with OCT angiography findings in the retinal capillaries. 52 Studies with larger numbers of patients are required to confirm that anti-VEGF treatment is not a major factor for the reduced blood flow observed in the present study.
Limitations
Because of its high speed, the en face Doppler volumetric scanning technique used in this study has 1 key limitation: when there are reflections from hyperreflective layers, such as the retinal nerve fiber layer, the inner-segment/outer-segment ellipsoid, and the retinal pigment epithelium, a nonzero Doppler phase can be detected even without any flow. Although our processing software can reduce these artifacts, it is difficult to completely remove the artifacts because the same axial flow velocity corresponds to a smaller Doppler phase at higher imaging speeds. These artifacts, especially in participants with low TRBF, can cause an overestimation or an underestimation of blood flow depending on the segmentation threshold. Manual inspection of the segmented flow velocity in the en face images is required in such cases. A solution for these artifacts is to increase the interscan time between the 2 A-scans paired for calculating Doppler phase. This can be achieved by doubling the density of the A-scans per unit length and pairing alternate, rather than subsequent, A-scans. This approach may require cardiac gating 27 because the volume sampling rate of 3.5 volumes per second may not be enough to accurately capture flow pulsatility. The other limitations of the study include its observational nature. Because our recruitment was not guided by a priori information from a pilot study, there are cohorts that have excessively small group sizes for statistical testing. However, this study itself may serve as a pilot study for future en face Doppler OCT investigations of TRBF in DR.
Conclusions
This study used high-speed en face Doppler OCT to investigate TRBF in diabetic eyes with or without DR and in healthy eyes. The TRBF was found to be significantly lower in the eyes with DME than in both the healthy eyes and the eyes with DR but without DME, regardless of retinopathy severity. In the eyes with moderate NPDR but without DME, we observed a strongly skewed TRBF distribution.
